Good evening. This snapshot of stories and roundup is recommended just for you, based on your interests and reading history. | | | | (Illustration by George Wylesol/For The Washington Post) | | | | | | |  What to know New research published in Nature Metabolism suggests glucosamine may accelerate Alzheimer's progression and increase mortality in patients with dementia. The study analyzed records from nearly 25,000 patients and found a 25% higher mortality risk for glucosamine users. Experts emphasize the need for further research and caution for those with dementia symptoms. Summary is AI-generated, newsroom-reviewed. | | | | | How was today's newsletter? | | | | | | | | |
Have a question? Ask the Post AI to learn more 
